Home|Journals|Articles by Year|Audio Abstracts
 

Original Research



Antibacterial Effects of Synthesized ZnO: Ag Nanoparticles against Listeria monocytogenes

Mojgan Dalirsaber Jalali, Khosro Issazadeh, Ali Abdolahzadeh Ziabari, Mirsasan Mirpour.




Abstract

Background and objective: Listeriosis is considered as one of the most significant food-borne diseases. Nanotechnology is perceived as a promising solution to produce and develop such new antibacterial substances.
Method: The present study synthesized ZnO and Ag-doped ZnO nanoparticles (ZnO:Ag NPs). The products of this study were under the effect of characterization by X-ray diffraction (XRD), scanning electron microscope (SEM) and Fourier-transform infrared spectroscopy (FTIR). This study tried to examine the antibacterial activities attributed to ZnO and ZnO:Ag NPs against Listeria monocytogenes by agar well diffusion method at six concentrations of 100, 50, 25, 12.5, 6.25, 3.12 μg/ml.
Results: A polyhedral form of the abovementioned unified nanoparticles was shown by SEM micrographs. Among the mentioned concentrations, treatment of 100, 50 and 25 μg/ml of ZnO:Ag NPs was completely inhibited the growth of L. monocytogenes in 24 h.
Conclusion: The results indicated that the appearance of Ag NPs in their hybrids (ZnO:Ag NPs) although in low content (

Key words: ZnO, ZnO:Ag NPs, Antibacterial activity, Listeria monocytogenes, agar well diffusion.






Full-text options


Share this Article


Online Article Submission
• ejmanager.com




ejPort - eJManager.com
Refer & Earn
JournalList
About BiblioMed
License Information
Terms & Conditions
Privacy Policy
Contact Us

The articles in Bibliomed are open access articles licensed under Creative Commons Attribution 4.0 International License (CC BY), which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.